Skip to main content
. Author manuscript; available in PMC: 2018 Jan 2.
Published in final edited form as: ACS Biomater Sci Eng. 2017 Sep 28;3(12):3273–3282. doi: 10.1021/acsbiomaterials.7b00600

Figure 5.

Figure 5

In vitro viability of prostate cancer cells. (A) In vitro cytotoxicity profiles of 22Rv1 and (B) PC3 after 72 h exposure to MCP-1 peptides, MCP-1 PAMs, scrambled peptides, and scrambled PAMs (n = 6).